InnoSer (@InnoSer_Labs) header
InnoSer (@InnoSer_Labs) profile picture

InnoSer is a young and innovative CRO, supporting biomedical companies in the fields of oncology, neurodegenerative, cardiovascular, and kidney diseases.

Diepenbeek, België
Joined October 2012
🎉 Thank you for 1500 followers! InnoSer supports preclinical drug development, ensuring personalized treatments. Your engagement helps us benefit researchers and drug developers. Together, we pave the way to better health!
1
31
🔬Our experts ensure animal health, freeing you to focus on research. With #AAALAC facilities in Belgium & the Netherlands, we offer tailored services. Struggling with vivarium space? Let's chat: innoserlaboratories.com/cont… 🐭 #PreclinicalCRO #ColonyManagement #VivariumOutsourcing
1
29
Join us in fighting skin cancer with our advanced models for melanoma drug development. Honor #SkinCancerAwarenessMonth by exploring our Oncology CRO services: innoserlaboratories.com/canc… #PreclinicalCancerResearch #InnoSer #MelanomaAwareness #PreclinicalCRO #EuropeanCROservices
58
Excited for #KFG2024! Meet our InnoSer team at booth #86! We hope to see you there to discuss our preclinical services: 🧪 Custom drug discovery 🏢 Facility management 🩺 Expertise in disease areas Can't make it? Email us at [email protected]! #PreclinicalCRO
29
Are you in #PreclinicalOncologyResearch? Join us at #MEET2WIN 2024 to explore how our team can advance your research! Don't miss meeting our rep @Amandine Boeckx! Can't make it? Email us at innoserlaboratories.com/cont…! #OncologyCRO #PreclinicalResearch
1
1
57
Macrophage-based assays emerge as a highly relevant way to assess your novel immunotherapeutics’ mechanism of action. At InnoSer, we offer PBMC-derived or human monocytic cell line-derived macrophages that can be studied in mono and co-culture settings: innoserlaboratories.com/news…
21
👉 The acute skin inflammation psoriasis model represents a time- and money-efficient way to model psoriasis in vivo, especially if quick initial efficacy data need to be generated: innoserlaboratories.com/blog…
40
Happy #FluorescenceFriday! The image below shows brain tissue obtained from a preclinical model of Alzheimer’s disease stained for Methoxy-X04. Discover how you can benefit from our histopathology service offering on our website: innoserlaboratories.com/path…
1
55
Last week, we shared some important news about our collaboration with @CR2O. Together, we're streamlining the preclinical to clinical trials pipeline with efficiency and precision. Catch up on our full press release here. #PreclinicalCRO #Clinicaltrials - innoserlaboratories.com/news…
17
Similarly to cancer patients, administration of chemotherapy in mice is associated with decline in cognitive performance. Together with researchers from NKI, we have previously shown that chemotherapy impacts a wide range of cognitive domains: pubmed.ncbi.nlm.nih.gov/2489…
12
Read more about how InnoSer’s expertise in the oncology field helps you obtain relevant insights beyond examining the efficacy profile of your novel therapeutic candidates here: innoserlaboratories.com/news…
14
Are you attending the upcoming Innovation For Health event on March 28th in Rotterdam? Then don't miss the chance to meet our business development manager Charlotte Wuyts to learn more about how you can accelerate your research with InnoSer!
29
Happy #FluorescenceFriday everyone! Below you can see a fluorescent microscopy image of organoid derived from pancreatic ductal adenocarcinoma (PDAC) samples, treated with standard of care chemotherapeutic, counterstained with DAPI and stained using viability dye PI.
80
Join InnoSer in raising awareness for kidney health on today's #WorldKidneyDay to ensure #KidneyHealthForAll! Learn more about the work that our team performs in the #ADPKD mouse model to help accelerate development of novel #ADPKD therapies here: innoserlaboratories.com/news…
43
🌟 Happy Employee Appreciation Day! 🌟 Big thanks to our amazing InnoSer team! Your dedication drives our success. From seamless communication to stellar support, you make it happen. CEO Jan Bartels shares his thoughts below. #EmployeeAppreciationDay #InnoSerTeam #PreclinicalCRO
16
Celebrating World Organoid Research Day 2024 Our PDX/O platform’s advantage lies in the fact that you can simultaneously evaluate your novel therapy's effects on the same parental tumours in both an in vitro 3D and in vivo research setting.: innoserlaboratories.com/canc…
32
At InnoSer, we work with both in vitro and in vivo models to help you research the different aspects of the disease. Learn how you can leverage InnoSer's preclinical research experience to advance your Parkinson's disease research here: innoserlaboratories.com/blog…
31
The key to understanding a therapeutic compound’s effect on amyloid-beta pathology-induced neuroinflammation, is to use robust and reliable models that consistently show progressive plaque pathology, such as the APP/PS1 (ARTE10) model: innoserlaboratories.com/news…
66